Charles River Laboratories | CRL - 流动资产

股票价格
169.80
每天变化
2.06 1.23%
每月一次
2.36%
每年
48.09%
Q2 预测
166.17


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.75B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


流动资产 更改 日
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Cardinal Health USD 39.23B 693M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cigna USD 47.81B 1.08B 2025-12
Concord Medical Services Hldg CNY 1.03B 174.49M 2025-06
CVS Health USD 74.71B 2.4B 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
Elevance Health USD 67.03B 4.03B 2026-03
Galapagos EUR 3.08B 82.56M 2025-12
Humana USD 32.73B 19M 2025-12
Illumina USD 3.29B 493M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Lonza CHF 8B 3.41B 2025-12
McKesson USD 59.7B 190M 2025-12
Merck EUR 13.23B 354M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Quest Diagnostics USD 2.57B 188M 2026-03
Revvity USD 2.24B 95.96M 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
United Therapeutics USD 3.7B 208.5M 2025-12
UnitedHealth USD 90.58B 4.49B 2025-12
Veradigm USD 679.65M 131.12M 2022-12
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.83B 151.4M 2026-03